Public stock offering pulls in $22.6M for InspireMD

04/23/2013 | MassDevice.com (Boston)

InspireMD has secured net proceeds of $22.6 million in a public offering of company shares. The Israeli device firm will use part of the funding to seek FDA approval of its MGuard carotid and coronary stents, which are used to prevent the risk of embolism in patients who have undergone stenting procedures.

View Full Article in:

MassDevice.com (Boston)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Consultant
Attest Health Care Advisors
Nationwide, SL_Nationwide
Biotechnology/Pharmaceutical Patent Attorney
Coats and Bennett PLLC
Cary, NC
Sr. Regulatory Specialist, Biotech Center of Expertise
BASF, The Chemical Co.
San Diego, CA
Food Lawyer
Cargill
Wayzata, MN
Actuary
Meridian Health Plan
Detroit, MI